18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard
Abstract
The PET tracer 18F-fluciclovine (Axumin) was recently approved in the United States and Europe for men with suspected prostate cancer recurrence following prior treatment. This article summarizes studies where systematic sector-based histopathology was used as reference standard to assess the diagnostic accuracy of the tracer 18F-fluciclovine PET in patients with prostate...
Paper Details
Title
18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard
Published Date
Apr 1, 2021
Journal
Volume
16
Issue
2
Pages
167 - 176
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History